The asexual erythrocytic cycle responsible for the clinical manifestations of malaria is perpetuated by merozoites which rupture out of infected erythrocytes and invade uninfected ones. Interaction between the merozoites and receptors on the erythrocyte surface initiate invasion (1-3). Chemical or immunologic interference between the merozoite and its receptor could block the infection at this point in the life cycle. Previously, we studied the characteristics of the erythroycte surface that are required for interaction and subsequent invasion by Plasmodium knowlesi merozoites (3, 4). Erythrocytes which lacked Duffy blood group determinants (Duffy negative erythrocytes) (3) or had been treated with chymotrypsin (4) were resistant to invasion. With the recent advances in in vitro cultivation ofPlasmodium falciparum (5, 6), it was possible to compare the erythrocyte surface determinants required for invasion by P. falciparum, the major malaria of man, and P. knowlesi, a monkey malaria that infects man.
The asexual erythrocytic cycle responsible for the clinical manifestations of malaria is perpetuated by merozoites which rupture out of infected erythrocytes and invade uninfected ones. Interaction between the merozoites and receptors on the erythrocyte surface initiate invasion (1-3). Chemical or immunologic
interference between the merozoite and its receptor could block the infection at this point in the life cycle. Previously, we studied the characteristics of the erythroycte surface that are required for interaction and subsequent invasion by Plasmodium knowlesi merozoites (3, 4). Erythrocytes which lacked Duffy blood group determinants (Duffy negative erythrocytes) (3) or had been treated with chymotrypsin (4) were resistant to invasion. With the recent advances in in vitro cultivation ofPlasmodium falciparum (5, 6), it was possible to compare the erythrocyte surface determinants required for invasion by P. falciparum, the major malaria of man, and P. knowlesi, a monkey malaria that infects man.
Materials and Methods
Human erythrocytes (test cells) which either lacked a blood group determinant (Table I) or had been treated with various enzymes (Table II) were exposed to P. falciparum and P. knowlesi merozoites in vitro, and the percentage of test cells infected was determined. Chimpanzee erythrocytes infected with P. falciparum (Camp strain) and frozen in liquid nitrogen were thawed (7) on the day of the experiment. They contained approximately 50% infected erythroeytes and varied in viability from experiment to experiment. The infected cells were centrifuged in microhematocrit tubes. Cells from the upper half of the tubes, containing about 90% infected erythrocytes were mixed with test erythrocytes in a ratio of 1 to 25 and cultured as previously described (6) . Erythrocytes were removed from culture 48 h later, spread in a thin film on a slide, stained with Giemsa, and the percent of erythrocytes infected with young trophozoites (ring forms) determined.
Rhesus erythrocytes that are refractory to invasion by P. falciparum were included in each experiment (Table I) . In parallel experiments, samples of test erythrocytes were cultured with P. Enzyme Treatment of Human Erythrocytes. Erythrocytes were treated with chymotrypsin and trypsin, and the enzymes were inhibited after treatment as described previously (3, 4, 8) . For neuraminidase treatment, a 20% suspension of erythrocytes in Tris-buffered saline with 3.6 mM KCI, 1.6 mM CaCl2, and 1.2 mM MgSO4, pH 7.4, was incubated with 25 U/ml of neuraminidase (Table I ). The two erythrocyte samples of the En(a-) phenotype showed a reduction in invasion by P. falciparum. Since a twofold decrease in invasion is within the range of variation between different individuals, it is not known if the reduced invasion was caused by the En(a-) phenotype or some other unrelated erythrocyte factor. In contrast to the small reduction in susceptibility of En(a-) cells to P. falciparum, Duffy negative cells (Fy[a-b-] ) are refractory to infection by P. knowlesi and rhesus cells are refractory to infection by P. falciparum (Table I ).
knowlesi-infected cells (3
The pattern of resistance of enzyme-treated human erythrocytes to infection differed for P. falciparum and P. knowlesi (Table II) . Chymotrypsin (0.1 mg/ml) treatment blocked infection by P. knowlesi but had no influence on infection by P. falciparum. Conversely, trypsin or trypsin plus neuraminidase caused a marked reduction in infection by P. falciparum but little or no change in susceptibility to P. knowlesi. Neuraminidase also caused a significant reduction in infection by P. falciparum, although the effect was less than that of trypsin or trypsin plus neuraminidase. Neuraminidase treatment did not block infection by P. knowlesi.
Discussion
In a previous study we observed directly the interaction between erythrocytes and P. knowlesi merozoites (9) . It consisted of attachment of the merozoite to the erythrocyte membrane followed by deformation and invasion. None of these events occurred when susceptible human erythrocytes were treated with chymotrypsin (Mason, S. J., L. H. Miller, and J. A. Dvorak. Unpublished data.), indicating that the receptor necessary for attachment of P. knowlesi was removed. In the present study chymotrypsin treatment (0.1 mg/ml) that blocks invasion byP. knowlesi had no effect on invasion byP. falciparum. On the other hand, treatment of human erythrocytes with trypsin or neuraminidase reduces invasion by P. falciparum but not by P. knowlesi. If P. falciparum invades erythrocytes by a similar mechanism to P. knowlesi, then infection of enzyme- treated erythrocytes by one but not the other parasite would suggest that the initial recognition phase is blocked by treatment with proteolytic enzymes and that different proteins or glycoproteins are involved in the recognition of each parasite. Moreover, the observation that erythrocytes remain susceptible to one of the two parasites after enzyme treatment indicates that the enzyme does not cause a nonspecific toxic effect.
We can speculate as to the nature of the P, falciparum-specific determinant(s) from the changes in the erythrocyte surface after enzyme treatments. As indicated by periodic acid Schiff staining of sodium dodecyl sulfate-polyacrylamide gels of enzyme-treated erythrocytes, trypsin (1 mg/rnl) removes more of the surface sialoglycopeptides (e.g., from glycophorins A and B) than does chyrnotrypsin (0.1 mg/ml) (8, 10). Trypsin (1 mg/ml)but not chymotrypsin (0.1 mg/rnl) causes reduction of invasion by P. falciparum. Removal of sialic acid by neura-minidase treatment also reduced infection. It is possible, therefore, that a sialoglycopeptide is the erythrocyte receptor for P. falciparum merozoites. Glycophorin A cannot be the sole receptor for P. falciparum, since infection of En(a-) cells, which lack this sialoglycoprotein (11, 12) , was not completely inhibited. Further investigations with purified erythrocyte membrane glycoproteins may resolve the nature of the receptor for P. falciparum.
Summary
Human erythrocytes lacking various blood group determinants were susceptible to invasion by Plasmodium falciparum including Duffy-negative erythrocytes that are refractory to invasion by Plasmodium knowlesi. Erythrocytes treated with trypsin or neuraminidase had reduced susceptibility to P. falciparum and normal susceptibility to P. knowlesi. Chymotrypsin treatment (0.1 mg! ml) blocked invasion only by P. knowlesi. The differential effect of enzymatic cleavage of determinants from the erythrocyte surface on invasion by these parasites suggests that P. falciparum and P. knowlesi interact with different determinants on the erythrocyte surface.
